Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4/A Insider Changes in Ownership
  5. 4 Open-market sale Director sold 920 shares at $12.51 ($11,509)
  6. 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $69.36 ($1,040,400)
  7. 4 Open-market sale President sold 75,000 shares at $60.00 ($4,500,000)
  8. 4 Open-market sale Director sold 44,000 shares at an average $57.99 ($2,551,440)
  9. 4 Open-market sale Director sold 44,000 shares at an average $57.99 ($2,551,440)
  10. 4 Open-market sale Director sold 650,000 shares at an average $54.39 ($35,352,456)
  11. 4 Other acquisition Director acquired 199 shares (other)
  12. 4 Open-market sale Director sold 121,362 shares at an average $50.39 ($6,115,873)
  13. 4 Open-market sale Director sold 128,950 shares at an average $50.39 ($6,497,892)
  14. 4 Open-market sale Director sold 30,566 shares at an average $50.29 ($1,537,138)
  15. 4 Open-market sale Director sold 30,566 shares at an average $50.29 ($1,537,138)
  16. 4 Open-market sale Director sold 222,258 shares at an average $50.11 ($11,136,437)
  17. 4 Open-market sale Director sold 222,258 shares at an average $50.11 ($11,136,437)
  18. 4 Open-market sale Director sold 22,841 shares at an average $50.99 ($1,164,655)
  19. 4 Open-market sale Director sold 22,841 shares at an average $50.99 ($1,164,655)
  20. 4 Open-market sale 10% owner sold 22,841 shares at an average $50.99 ($1,164,655)

Page 19 of 26 · 502 filings